Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$6.78 - $9.04 $101,110 - $134,813
-14,913 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.18 - $23.98 $121,988 - $357,613
14,913 New
14,913 $126,000
Q3 2020

Nov 16, 2020

SELL
$18.75 - $28.58 $149,156 - $227,353
-7,955 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$15.6 - $54.87 $124,098 - $436,490
7,955 New
7,955 $220,000

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.